{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:58:55Z","timestamp":1758124735511},"reference-count":21,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T00:00:00Z","timestamp":1189036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Flutamide and cyproterone acetate (CPA) are both oral anti\u2010androgens commonly used to treat advanced prostatic cancer. We report a case of drug\u2010induced hepatotoxicity after consecutive treatment with flutamide and CPA. A 78\u2010year\u2010old male with advanced prostatic adenocarcinoma had been treated with flutamide 750\u2003mg\/day p.o. and leuproleride acetate 22.5\u2003mg\/3 months i.m. Three months later, the patient complained of choluria and jaundice. Laboratory examination revealed severe hepatocellular insufficiency. Flutamide\u2010induced hepatotoxicity was suspected and therefore flutamide was withdrawn. His liver function abnormalities resolved after drug discontinuation. He was subsequently started on CPA 150\u2003mg\/day and again developed hepatotoxicity with severe hepatocellular impairment, which completely recovered after drug discontinuation. Other causes of acute liver failure were appropriately ruled out in both episodes and there was no evidence of active prostate cancer or liver metastases in both episodes. The occurrence of hepatotoxicity associated with flutamide and CPA on separated occasions suggests the possibility of a common mechanism of injury. It may become necessary to reassess the common practice of switching to another anti\u2010androgen when hepatotoxicity appears. A closer monitoring of liver enzymes might be necessary in such cases, as an increased risk of a new severe hepatotoxicity event cannot be ruled out.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2007.01549.x","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T08:54:07Z","timestamp":1189241647000},"page":"1144-1147","source":"Crossref","is-referenced-by-count":19,"title":["Suspected cross\u2010hepatotoxicity of flutamide and cyproterone acetate"],"prefix":"10.1111","volume":"27","author":[{"given":"Mireia","family":"Miquel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aina","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vaqu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ojanguren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,9,6]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000020504.41500.9c"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02071403"},{"key":"e_1_2_4_4_2","first-page":"419","article-title":"Flutamide induced hepatotoxicity","volume":"93","author":"Garc\u00eda Cort\u00e9s M","year":"2001","journal-title":"report of a case series"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-11-199306010-00006"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP39395"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66596-0"},{"key":"e_1_2_4_8_2","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0022-5347(17)37071-4","article-title":"Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer","volume":"148","author":"Dankoff J.","year":"1992","journal-title":"J Urol"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(94)80006-5"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90144-G"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10426"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026639432428"},{"key":"e_1_2_4_13_2","first-page":"161","article-title":"Acute hepatic necrosis in a patient treated with cyproterone acetate","volume":"19","author":"Lombardi A","year":"1998","journal-title":"G Chir"},{"key":"e_1_2_4_14_2","first-page":"1","article-title":"Hepatic reactions with cyproterone acetate (Cyprostat, Androcur)","volume":"21","author":"Committee on Safety of Medicines\/Medicines Control Agency.","year":"1995","journal-title":"Curr Probl"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.5.556"},{"key":"e_1_2_4_16_2","first-page":"3","article-title":"High dose cyproterone and hepatotoxicity","volume":"23","author":"Anon ymous.","year":"2004","journal-title":"Aust Adv Drug React Bull"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199410000-00006"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90373-5"},{"key":"e_1_2_4_19_2","first-page":"1323","article-title":"Causality assessment of adverse reactions to drugs I. A novel method based on the conclusion of international consensus meetings","volume":"46","author":"Danan G","year":"1993","journal-title":"application to drug-induced liver injuries"},{"key":"e_1_2_4_20_2","first-page":"278","article-title":"Liver failure caused by flutamide","volume":"21","author":"Guzman Martinez\u2010Valls PL","year":"1997","journal-title":"Actas Urol Esp"},{"key":"e_1_2_4_21_2","first-page":"289","article-title":"Hepatotoxicity induced by antiandrogens","volume":"73","author":"Thole Z","year":"2004","journal-title":"a review of the literature"},{"key":"e_1_2_4_22_2","first-page":"954","article-title":"Toxicity of antiandrogen flutamide in isolated rat hepatocytes","volume":"269","author":"Fau D","year":"1994","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2007.01549.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2007.01549.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:40:05Z","timestamp":1697298005000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2007.01549.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,6]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1478-3231.2007.01549.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2007.01549.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,6]]}}}